Development · 9 Sep 2026

Torrent Pharmaceuticals has been outperforming peers in the domestic pharma market, which accounts for about 50-55 per cent of its revenues and remains the key growth driver of consolidated performance.

1 publisher has reported this development. Each act of reporting is below, cited.

The record

business-standard.com9 Sep 2026

A single act of reporting so far, corroborating sources join this record as they publish.

Torrent Pharmaceuticals

₹4,767.30

▼ -0.68%

Close (EOD), as of 1 Oct 2026 · source

Torrent Pharmaceuticals: results, dividends, orders, the full cited record →

More on Torrent Pharmaceuticals

Torrent Pharmaceuticals Ltd has increased its proposed investment in Torrent Urja 27 Pvt Ltd to ₹11.88 crore to acquire a 26 per cent stake.

28 Sep 2026 · 1 publisher

India's 10 largest pharmaceutical companies have maintained positive average volume growth through every month of 2026 so far, while smaller rivals have seen a more uneven performance.

20 Sep 2026 · 1 publisher

- Sun Pharmaceutical Industries Share Price - Divi's Laboratories Share Price - Torrent Pharmaceuticals Share Price - Cipla Share Price - Zydus Lifesciences Share Price ...

22 Aug 2026 · 1 publisher

Every claim carries its citation

This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.

New here? The reader's guide explains every page, plate by plate.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.